Ipamorelin 2 mg
Educational recon guide for a 2 mg Ipamorelin research vial and microgram pulse unit mapping. Research use only.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
2 mg
Your BAC water
1 mL
Concentration
2.00 mg/mL
Per unit
~20.0 mcg
Frequency
1–3× daily subcutaneous (often bedtime; sometimes AM + PM)
Route
Subcutaneous
Live reconstitution calculator
Defaults match this guide (2 mg + 1 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
This guide uses microgram-scale research doses — quick picks are in mcg (100 mcg = 0.1 mg).
Quick select (mcg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
5 units
Volume
0.050 mL
Doses per vial
20
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 5 u
Fill one 30-unit U-100 syringe to about 5 units (0.050 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (1 mL BAC → 2.00 mg/mL · 20.0 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Research-community and clinic educational tables commonly use ~100–300 mcg per injection, 1–3 times daily. Frequently paired with CJC-1295 (no DAC) / Mod GRF at similar mcg amounts.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Days 1–14 (intro) | 100 mcg0.1 mg | 5 u | 0.05 mL100 mcg per injection — common educational start |
| Days 15–42 (standard) | 200 mcg0.2 mg | 10 u | 0.10 mL200 mcg per injection — frequently cited amount |
| Days 43–70 (optional) | 300 mcg0.3 mg | 15 u | 0.15 mL300 mcg per injection — upper common pulse range |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Higher pulse · 500 mcg | 500 mcg0.5 mg | 25 u | 0.25 mLAbove many standard tables — educational only |
Supplies planner
Using the guide’s phase ladder (100 mcg → 200 mcg → 300 mcg per injection (phase ladder)) over a 70-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
1 mL · 2.00 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
70-day course
Ipamorelin 2 mg vials
8 vials
~15.4 mg mg total peptide over this 70-day course at 100 mcg → 200 mcg → 300 mcg per injection (phase ladder). Each vial holds 2 mg.
Bacteriostatic water
3 × 3 mL or 1 × 10 mL
1 mL BAC per vial × 8 vials = 8.0 mL total. Buy as 3× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
70+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~156 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 2 mg Ipamorelin vial and bacteriostatic water to reach room temperature.
- Draw 1.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "2.0 mg/mL — 1 mL BAC").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·Ipamorelin is a selective ghrelin-mimetic GH secretagogue (generally milder hunger than GHRP-6).
- ·Calculator: 0.1 mg = 100 mcg; 0.2 mg = 200 mcg.
- ·See also the CJC+IPA blend guide for fixed-ratio stacks.
- ·Research use only.
Research context & considerations
Ipamorelin is widely discussed as a selective GHRP-class secretagogue with human experimental GH-release data. Research vials are not approved GH therapies.
- ·Water retention, tingling, and mild hunger can appear.
- ·GH-axis malignancy and metabolic cautions apply.
- ·Not FDA-approved as a research-vial product.
- ·Pregnancy out of scope.
Catalog match
Ipamorelin (IP2)
2mg x 10 vials · from $10